Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Melanoma · Multiple Myeloma · RNA

Atrium Therapeutics

Atrium Therapeutics patent portfolio — 37 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
10578 Science Center Dr, Suite 125, San Diego, California 92121, US HQ
2026 Founded
46 Employees
Public company Type
RNA · NYSE Ticker
Company details
Status
Public
HQ
10578 Science Center Dr, Suite 125, San Diego, California 92121, US
Founded
2026
Employees
46
Programs
31
Drugs
33
Patents
37
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Atrium Therapeutics patents

37 pharmaceutical patents indexed for Atrium Therapeutics. 0 expire within 24 months.

Atrium Therapeutics has 37 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

37 patents

Patent portfolio

  1. US 11793912

    Cross-linked fatty acid-based biomaterials

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11166929

    Fatty-acid based particles

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11097035

    Compositions and methods for altering the rate of hydrolysis of cured oil-based materials

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11083823

    Tissue-separating fatty acid adhesion barrier

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10888617

    Cured oil-hydrogel biomaterial compositions for controlled drug delivery

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10869902

    Cured gel and method of making

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10864304

    Anti-infective antimicrobial-containing biomaterials

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10814043

    Cross-linked fatty acid-based biomaterials

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10792312

    Barrier layer

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10772995

    Cross-linked fatty acid-based biomaterials

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10603153

    Hernia patch

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10322213

    Compositions and methods for altering the rate of hydrolysis of cured oil-based materials

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10285964

    Fatty-acid based particles

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10016465

    Cured gel and method of making

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9867880

    Cured oil-hydrogel biomaterial compositions for controlled drug delivery

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9844611

    Tissue-separating fatty acid adhesion barrier

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9827353

    Cross-linked fatty acid-based biomaterials

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9827352

    Cross-linked fatty acid-based biomaterials

    Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9801913

    Barrier layer

    Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9682175

    Coating material and medical device system including same

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9427423

    Fatty-acid based particles

    Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9278161

    Tissue-separating fatty acid adhesion barrier

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9012506

    Cross-linked fatty acid-based biomaterials

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9000040

    Cross-linked fatty acid-based biomaterials

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8962023

    UV cured gel and method of making

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8858978

    Heat cured gel and method of making

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8795703

    Stand-alone film and methods for making the same

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8722077

    Drug delivery coating for use with a stent

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8722132

    Application of a coating on a medical device

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8574618

    Perforated bioabsorbable oil film and methods for making the same

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8501229

    Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8460693

    Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8367099

    Perforated fatty acid films

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8263102

    Drug delivery coating for use with a stent

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8124127

    Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8001922

    Application of a coating on a medical device

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7572245

    Application of a therapeutic substance to a tissue location using an expandable medical device

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Atrium Therapeutics have?

37 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Atrium Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.